The presence of PKM2 in tumour cells can inhibit OXPHOS by inhibiting the expression of monoubiquitinated histone H2B (H2Bub1) and enhance pyruvate phosphorylation in glycolysis to influence metabolic rearrangement. The gene discussed is PKM; the disease is neoplasm.